Delivery Order 36F79725D0061-15B50926F00000094

<p>The Federal Correctional Institution Fort Worth issued a $5,984.59 delivery order to Helsinn Therapeutics (U.S.), Inc. on August 1, 2026, under the GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) for VALCHLOR gel (0.01265%), a treatment for cutaneous T-cell lymphoma.</p> <p>Place of performance is Iselin, NJ. The order carries a firm fixed price and an ultimate completion date of August 31, 2026. No set-aside was used.</p>

Helsinn Therapeutics (U.S.), Inc. was awarded a delivery order valued at $5,984.59 on May 1, 2026, by the Federal Correctional Institution Fort Worth for the supply of VALCHLOR gel, a pharmaceutical product used to treat cutaneous T-cell lymphoma. This firm fixed-price delivery order, with an ultimate completion date of May 30, 2026, carries no set-aside designation and will be fulfilled from the vendor's position on the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration...

The Federal Correctional Institution Fort Worth awarded a delivery order to Actelion Pharmaceuticals US, Inc. on April 1, 2026, with a ceiling value of $61,988.37 and completion date of April 30, 2026. This firm fixed-price delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a multiple-award schedule valued at $219.1 million with a performance period extending through July 31, 2029. The award carries no set-aside designation, and the ordering is...

The Federal Correctional Institution Fort Worth issued a $61,988.37 delivery order to Actelion Pharmaceuticals US, Inc. on August 1, 2026, under the GSA Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, for Actelion pulmonary arterial hypertension medications (Uptravi and Opsumit) with an ultimate completion date of August 31, 2026. The FSS-61-IB schedule is a multiple-award vehicle valued at $219.1 million with a period of performance through July 31, 2029, enabling federal...

The Federal Correctional Institution Fort Worth awarded a delivery order valued at $61,988.37 to Actelion Pharmaceuticals US, Inc. for pharmaceutical supplies under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This firm fixed-price delivery order, issued on September 1, 2026, with a completion date of September 30, 2026, procures Uptravi and Opsumit—specialized medications used to treat pulmonary arterial hypertension and related rare diseases. The order carries no small...

<p>The Federal Correctional Institution Greenville issued a $20,000 delivery order to McKesson Corporation on May 1, 2026, for medication and medical supplies with a completion date of May 31, 2026.</p> <p>The order is issued under firm fixed price terms with no set-aside applied. Place of performance is Irving, TX.</p>

<p>The Federal Correctional Institution Loretto issued a $92,332.87 delivery order to McKesson Corporation on June 1, 2026, for contract medications with a ceiling value of $92,332.87 and an ultimate completion date of June 30, 2026.</p> <p>Place of performance is Irving, TX. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>Federal Correctional Institution Loretto issued a delivery order to McKesson Corporation on March 1, 2026, for medications with a ceiling value of $61,352.11 and an ultimate completion date of March 31, 2026.</p> <p>Place of performance is Irving, TX. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The Federal Correctional Institution Beckley issued a $23,668.22 delivery order to McKesson Corporation on April 1, 2025, for regular medications under a firm fixed price structure.</p> <p>Place of performance is Irving, TX. The order has an ultimate completion date of April 30, 2025. No set-aside was used.</p>

<p>Federal Correctional Institution Three Rivers issued a $4,500 delivery order to McKesson Corporation on July 1, 2026, for regular medication supply through the end of fiscal year 2026.</p> <p>Place of performance is Irving, TX. The order is firm fixed price with an ultimate completion date of September 30, 2026.</p>